DIAMYD ACQUIRES AMERICAN BIOTECHNOLOGY COMPANY NUREL THERAPEUTICS, INC.

Diamyd Medical AB (OMX:DIAMB), today announced that it has agreed to acquire all of the outstanding shares in Nurel, a Pittsburgh, PA-based biotechnology company. The merger is subject to approval by the board of directors of each company and their respective shareholders. The Diamyd Medical Board of Directors plans to request shareholder approval for the merger at the Annual General Shareholders Meeting on December 12th.

PrimeZone (http://www.primezone.com/newsroom/news.html?d=90204)